Anti-aging shot for eye disease edges closer to reality

A Boston biotech startup injects its archetypal quality diligent with an anti-aging changeable designed to marque cells enactment younger.

A Boston biotech startup announced a large measurement towards reversing age-related imaginativeness loss. Their experimental cistron therapy, ER100, aims to reprogram cells, making them enactment younger. Life Biosciences co-founder Dr. David Sinclair explains this attraction combats aging by addressing epigenetic accusation loss. This marks a milestone FDA quality proceedings successful the subject of aging.